Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at [email protected].

Home

sheeba farhat

Articles By : sheeba farhat

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

USFDA Flags Liver Safety Concerns, Asks Eli Lilly for Additional Data on Obesity Pill Foundayo

Written By sheeba farhat15 April 2026 7:35 PM IST

New Delhi: The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved obesity pill,...

Amazon Enters Drug Discovery Race with AI Platform for Faster Molecule Design

Written By sheeba farhat15 April 2026 7:13 PM IST

Bengaluru: Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an artificial intelligence application designed to speed early-stage drug...

AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation

Written By sheeba farhat15 April 2026 7:00 PM IST

New Delhi: Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic...

GSK's Mo-rez Shows Strong Tumor Reduction Data, Tipped as Potential Blockbuster Cancer Drug

Written By sheeba farhat14 April 2026 8:07 PM IST

London: British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology ‌research has ⁠told...

Govt Plans CDSCO Restructuring, 1,500+ Subject Experts to Be Hired

Written By sheeba farhat14 April 2026 8:01 PM IST

New Delhi: India is best positioned to play a leading role as the global pharmaceutical landscape evolves with increasing emphasis on biologics,...

Travere's Filspari Becomes First USFDA-Approved Drug for FSGS Treatment

Written By sheeba farhat14 April 2026 7:50 PM IST

New Delhi: The U.S. Food and Drug Administration (USFDA) has approved the expanded use of Travere Therapeutics' drug to treat a rare kidney disorder,...

OneSource Strengthens CDMO Play as Partner Secures USFDA Tentative Approval for Ozempic Generic

Orbicular Pharma, Apotex Secure USFDA Tentative Nod for Generic Ozempic

Written By sheeba farhat13 April 2026 6:33 PM IST

Hyderabad: Orbicular Pharmaceutical Technologies on Saturday announced that a generic version of Ozempic (semaglutide injection), developed in...

Pharma, Healthcare Firms Set for 11% Growth in Q4, Margins Under Pressure: HDFC Securities

Written By sheeba farhat13 April 2026 6:17 PM IST

Mumbai: The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

C4 Therapeutics, Roche Ink USD 1 Billion Cancer Drug Deal for Novel DAC Therapies

Written By sheeba farhat12 April 2026 10:30 AM IST

New Delhi: C4 Therapeutics, opens new tab said on Thursday it has entered into a deal focused on research and development of ‌a type of cancer drug...

USFDA Rejects Replimune's RP1 for Advanced Melanoma, Flags Insufficient Data

Written By sheeba farhat11 April 2026 11:17 PM IST

Bengaluru: The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug for advanced skin cancer citing insufficient data...

China Approves Amgen's Tarlatamab (Imdelltra) for Advanced Small Cell Lung Cancer

Written By sheeba farhat11 April 2026 11:11 PM IST

Shanghai: Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and...

McKinsey to Pay USD 125 Million in Purdue Opioid Settlement Over OxyContin Sales Advice

Written By sheeba farhat11 April 2026 11:02 PM IST

New York: Consulting firm McKinsey & Co has agreed to contribute USD 125 million to Purdue Pharma's bankruptcy settlement, resolving potential...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok